Login

NON-SUBSCRIBER OPTIONS
FREE TRIAL   |   NEWSSTAND

FDA Details How Drug, Biologic Sponsors Can Use RWE In Applications

May 09, 2019
FDA issued draft guidance explaining how drug and biologic sponsors can document their use of real-world evidence in drug and biologics applications, in a bid to encourage industry use of such evidence to seek product approvals or labeling changes. Identifying the use of such data in a simple, uniform format will also help the agency track use of real-world evidence in regulatory submissions, the draft guide says. FDA plans to host a webinar on the draft guidance in mid-to-late May...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.